Administration of acetylcholine and vasoactive intestinal polypeptide to atopic eczema patients.

Rukwied, R; Heyer, G

Rukwied, R; Heyer, G.

Affiliation

Rukwied R; Department of Dermatology, University of Erlangen/Nürnberg, Erlangen, Germany.

Exp Dermatol ; 8(1): 39-45, 1999 Feb.

Article in En | MEDLINE | ID: mdl-10206720

Subject(s)

Acetylcholine/pharmacology; Cholinergic Agents/pharmacology; Dermatitis, Atopic/physiopathology; Skin/drug effects; Vasoactive Intestinal Peptide/pharmacology; Acetylcholine/adverse effects; Adult; Cetirizine/pharmacology; Cetirizine/therapeutic use; Cholinergic Agents/adverse effects; Cross-Over Studies; Dermatitis, Atopic/drug therapy; Double-Blind Method; Erythema/chemically induced; Erythema/pathology; Female; Histamine H1 Antagonists/pharmacology; Histamine H1 Antagonists/therapeutic use; Humans; Injections, Intradermal; Male; Pain/chemically induced; Pain/physiopathology; Pruritus/chemically induced; Pruritus/physiopathology; Psychophysics; Skin/pathology; Skin/physiopathology; Vasoactive Intestinal Peptide/adverse effects

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Skin / Vasoactive Intestinal Peptide / Acetylcholine / Cholinergic Agents / Dermatitis, Atopic Type of study: Clinical_trials Limits: Adult / Female / Humans / Male Language: En Journal: Exp Dermatol Year: 1999 Document type: Article

Search on Google

XML

PubMed Links